Document Page: First | Prev | Next | All | Image | This Release | Search

    C. MEDICAL PERSONNEL EXPECTING TO HAVE BLOOD AND SALIVA EXPOSURE
    WILL RECEIVE AT LEAST ONE DOSE OF HEPATITIS B VACCINE UNLESS THE
    THREE-DOSE SERIES HAS ALREADY BEEN COMPLETED.
    D. MENINGCOCCAL VACCINE IS NOT REQUIRED BUT IS RECOMMENDED IF PRO-
    LONGED CLOSE CONTACT WITH LOCAL NATIONAL CITIZENS, ESPECIALLY
    CHILDREN, IS ANTICIPATED. PERSONNEL EXPECTING TO WORK IN REFUGEE
    CAMPS SHOULD BE VACCINATED.
    3. MALARIA PROPHYLAXIS:
    A. CHLOROQUINE IS ONLY REQUIRED FOR PERSONNEL EXPECTING TO BE
    PRESENT FOR AT LEAST 5 CONSECUTIVE DAYS IN THE FOLLOWING AREAS DURING
    RISK PERIODS: {1} OMAN, YEAR ROUND; {2} JIZAN PROVINCE OF SAUDI
    ARABIA {NOT INCLUDING KHAMIS MUSHAIT}, YEAR ROUND; {3} DAHUK, NIMAWA,
    IRBIL AND AS SULAYMANIYAH PROVINCES OF IRAQ {ALL NORTHERN PROVINCES}
    MAY TO NOVEMBER; {4} RURAL AREAS IN SOUTHEAST TURKEY AND ALONG THE
    MEDITERRANEAN COAST, EAST OF ANTALYA, FEBRUARY TO NOVEMBER.
    B. AVOIDANCE OF MOSQUITO BITES IS THE PREFERRED METHOD OF MALARIA
    PREVENTION. PERSONAL PROTECTIVE MEASURES INCLUDE PROPER WEAR OF THE
    BATTLE DRESS UNIFORM, USE OF INSECT REPELLENTS, AND TREATMENT OF THE
    BATTLE DRESS UNIFORM, BEDNETS AND TENTAGE WITH THE RECENTLY APPROVED
    PERMETHRIN SPRAY {NSN 6840-01-334-2666}. CHLOROQUINE IS THE
    
      

Document Page: First | Prev | Next | All | Image | This Release | Search